ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 73 filers reported holding ENZO BIOCHEM INC in Q2 2021. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $65,666 | -73.2% | 27,023 | -65.0% | 0.00% | – |
| Q2 2021 | $245,000 | +390.0% | 77,317 | +435.2% | 0.00% | – |
| Q1 2021 | $50,000 | -9.1% | 14,447 | -44.3% | 0.00% | – |
| Q3 2020 | $55,000 | -52.6% | 25,915 | -24.8% | 0.00% | – |
| Q2 2019 | $116,000 | +34.9% | 34,444 | +120.3% | 0.00% | – |
| Q1 2018 | $86,000 | -27.7% | 15,633 | -60.1% | 0.00% | -100.0% |
| Q2 2015 | $119,000 | – | 39,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |